As of 2026-09-11, the Relative Valuation of SQZ Biotechnologies Co (SQZ) is (60.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.44 USD, the upside of SQZ Biotechnologies Co based on Relative Valuation is -13944.2%.
The range of the Relative Valuation is (53.67) - (60.79) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.9x - 22.6x | 21.0x |
| Forward P/E multiples | 19.0x - 26.8x | 23.7x |
| Fair Price | (53.67) - (60.79) | (60.22) |
| Upside | -12439.0% - -14074.3% | -13944.2% |
| Date | P/E |